MedPath

Observational Study of How Patients Take Eye Drops

Conditions
Glaucoma
Interventions
Device: MEMS cap
Registration Number
NCT00750646
Lead Sponsor
Robin, Alan L., M.D.
Brief Summary

This study is interested in monitoring how patients take eye drops, both through video-recordings and adherence monitoring, as well as their perceptions about their eye medications; including the dosing schedules, instillation techniques and effect on their disease.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
220
Inclusion Criteria
  • >18 year old
  • currently taking 1 or more hypotensive topical eye drops takes drops in the right eye for more than 6 months expect to continue drop use for the next 3 months
  • subjects instill their own eye drops
  • subject is able to take HVF tests
  • subject will expect to complete the 3 months enrollment period
Exclusion Criteria
  • unable/unwilling to instill own medications
  • eye drops are discontinued
  • unable to take HVF test
  • unable to complete follow-up
  • investigators discontinue subject for safety reasons
  • not using drops in left eye

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
AMEMS capSubject's adherence to prescribed therapy will be monitored with an electronic compliance device.
Primary Outcome Measures
NameTimeMethod
Medication adherence measured by MEMS caps3 months
Eye drop technique measured by video evaluation1 time observation
Secondary Outcome Measures
NameTimeMethod
Medication adherence measured by self-report3 months
Severity of VF damage1 test date
Intraocular pressure readings3 months

Trial Locations

Locations (1)

Glaucoma Specialists

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath